INS and type 2 diabetes mellitus: We examined how CGM influences patient-reported outcomes and whether changes in those outcomes predict glycemic improvement.<h4>Research design and methods</h4>This 6-month prospective observational study included 115 adults with T2D and elevated HbA1c who did not use fast-acting insulin and initiated CGM through a real-world program.